These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 28182570)
1. Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. Guglielmetti L; Jaspard M; Le Dû D; Lachâtre M; Marigot-Outtandy D; Bernard C; Veziris N; Robert J; Yazdanpanah Y; Caumes E; Fréchet-Jachym M; Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28182570 [TBL] [Abstract][Full Text] [Related]
2. Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety. Gao JT; Du J; Wu GH; Pei Y; Gao MQ; Martinez L; Fan L; Chen W; Xie L; Chen Y; Wang H; Jin L; Li GB; Zong PL; Xiong Y; Wu QH; Li MW; Yan XF; Miao YF; Cai QS; Li XJ; Bai DP; Geng SJ; Yang GL; Tang PJ; Zeng Y; Chen XH; Li TX; Cai C; Zhou Y; Zhuo M; Wang JY; Guan WL; Xu L; Shi JC; Shu W; Cheng LL; Teng F; Ning YJ; Xie SH; Sun YX; Zhang LJ; Liu YH Infect Dis Poverty; 2021 Mar; 10(1):32. PubMed ID: 33736710 [TBL] [Abstract][Full Text] [Related]
3. Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort. Guglielmetti L; Le Dû D; Jachym M; Henry B; Martin D; Caumes E; Veziris N; Métivier N; Robert J; Clin Infect Dis; 2015 Jan; 60(2):188-94. PubMed ID: 25320286 [TBL] [Abstract][Full Text] [Related]
4. Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study. Ferlazzo G; Mohr E; Laxmeshwar C; Hewison C; Hughes J; Jonckheere S; Khachatryan N; De Avezedo V; Egazaryan L; Shroufi A; Kalon S; Cox H; Furin J; Isaakidis P Lancet Infect Dis; 2018 May; 18(5):536-544. PubMed ID: 29452942 [TBL] [Abstract][Full Text] [Related]
5. High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen. Ndjeka N; Schnippel K; Master I; Meintjes G; Maartens G; Romero R; Padanilam X; Enwerem M; Chotoo S; Singh N; Hughes J; Variava E; Ferreira H; Te Riele J; Ismail N; Mohr E; Bantubani N; Conradie F Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361246 [TBL] [Abstract][Full Text] [Related]
6. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis. Centers for Disease Control and Prevention MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696 [TBL] [Abstract][Full Text] [Related]
7. Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study. Gao M; Gao J; Xie L; Wu G; Chen W; Chen Y; Pei Y; Li G; Liu Y; Shu W; Fan L; Wu Q; Du J; Chen X; Tang P; Xiong Y; Li M; Cai Q; Jin L; Mei Z; Pang Y; Li L Clin Microbiol Infect; 2021 Apr; 27(4):597-602. PubMed ID: 32553880 [TBL] [Abstract][Full Text] [Related]
8. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis. Worley MV; Estrada SJ Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970 [TBL] [Abstract][Full Text] [Related]
9. Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea. Kim CT; Kim TO; Shin HJ; Ko YC; Hun Choe Y; Kim HR; Kwon YS Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29545276 [TBL] [Abstract][Full Text] [Related]
10. Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis. Achar J; Hewison C; Cavalheiro AP; Skrahina A; Cajazeiro J; Nargiza P; Herboczek K; Rajabov AS; Hughes J; Ferlazzo G; Seddon JA; du Cros P Emerg Infect Dis; 2017 Oct; 23(10):1711-3. PubMed ID: 28758889 [TBL] [Abstract][Full Text] [Related]
12. A safety evaluation of bedaquiline for the treatment of multi-drug resistant tuberculosis. Cohen K; Maartens G Expert Opin Drug Saf; 2019 Oct; 18(10):875-882. PubMed ID: 31339384 [No Abstract] [Full Text] [Related]
13. Twenty-four-week interim outcomes of bedaquiline-containing regimens in treatment of adolescents with rifampicin-resistant tuberculosis: A retrospective cohort study in China. Wu HY; Tian Y; Wang XD; Sun JS; Fan LC; Chen MX; Li R; Chen Y J Paediatr Child Health; 2022 Jan; 58(1):116-121. PubMed ID: 34323328 [TBL] [Abstract][Full Text] [Related]
14. Effects of Bedaquiline Combined with Fluoroquinolone and/or Clofazimine on QT Interval in Patients with Multidrug-Resistant Tuberculosis: a Retrospective Study. Li R; Ma JB; Yang H; Yang H; Yang XJ; Wu YQ; Ren F Microbiol Spectr; 2023 Aug; 11(4):e0104823. PubMed ID: 37310268 [TBL] [Abstract][Full Text] [Related]
15. Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis. Pai H; Ndjeka N; Mbuagbaw L; Kaniga K; Birmingham E; Mao G; Alquier L; Davis K; Bodard A; Williams A; Van Tongel M; Thoret-Bauchet F; Omar SV; Bakare N BMC Infect Dis; 2022 Nov; 22(1):870. PubMed ID: 36414938 [TBL] [Abstract][Full Text] [Related]
16. Is 6 months of bedaquiline enough? Results from the compassionate use of bedaquiline in Armenia and Georgia. Hewison C; Bastard M; Khachatryan N; Kotrikadze T; Hayrapetyan A; Avaliani Z; Kiria N; Yegiazaryan L; Chumburidze N; Kirakosyan O; Atshemyan H; Qayyum S; Lachenal N; Varaine F; Huerga H Int J Tuberc Lung Dis; 2018 Jul; 22(7):766-772. PubMed ID: 29914602 [TBL] [Abstract][Full Text] [Related]
17. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis. Chahine EB; Karaoui LR; Mansour H Ann Pharmacother; 2014 Jan; 48(1):107-15. PubMed ID: 24259600 [TBL] [Abstract][Full Text] [Related]
18. Bedaquiline versus injectable containing regimens for rifampicin-resistant and multidrug-resistant tuberculosis in a reference center in Brazil - a real-world evidence study using a retrospective design. Santos AP; Benace CJ; de Medeiros Leung JA; Kritski AL; de Queiroz Mello FC BMC Infect Dis; 2024 Oct; 24(1):1112. PubMed ID: 39375590 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study. Brust JCM; Gandhi NR; Wasserman S; Maartens G; Omar SV; Ismail NA; Campbell A; Joseph L; Hahn A; Allana S; Hernandez-Romieu AC; Zhang C; Mlisana K; Viljoen CA; Zalta B; Ebrahim I; Franczek M; Master I; Ramangoaela L; Te Riele J; Meintjes G Clin Infect Dis; 2021 Dec; 73(11):2083-2092. PubMed ID: 33882121 [TBL] [Abstract][Full Text] [Related]
20. Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis. Nguyen TV; Cao TB; Akkerman OW; Tiberi S; Vu DH; Alffenaar JW Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1025-37. PubMed ID: 27322153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]